Welcome to our systemic inoculation model platform, specially designed for pre-clinical research on hematologic tumor drugs. Recognizing the uniqueness of hematologic tumors, we've developed this advanced model platform to ensure a more accurate and efficient drug evaluation and research process.
Platform Features and Applications:
• Flow Cytometry Analysis: Our platform utilizes flow cytometry technology, enabling precise detection and analysis of the quantity, activity, and drug interactions of hematologic tumor cells.
• In Vivo Fluorescence Imaging: This technology allows for real-time, non-invasive monitoring of the distribution, growth, and drug response of hematologic tumor cells in the body, providing key dynamic data for drug evaluations.
• Integration with the iHuPBMC Model: By combining with our iHuPBMC model, this platform can simulate not only the growth and spread of tumors but also delve deeply into the effects of tumor immunotherapies. This provides a comprehensive and realistic simulation environment for your immunotherapy research.
Our systemic inoculation platform for hematologic tumor research integrates a multitude of cutting-edge techniques, aiming to offer robust support for your hematologic tumor drug and immunotherapy development. Should you have any questions or require further insights, please don't hesitate to contact us.